financetom
Business
financetom
/
Business
/
Enphase Energy Stock Is Diving Wednesday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enphase Energy Stock Is Diving Wednesday: What's Going On?
Oct 23, 2024 6:48 AM

Enphase Energy Inc ( ENPH ) shares are trading lower Wednesday after the company reported worse-than-expected financial results for the third quarter. The selloff has accelerated Wednesday morning as multiple analyst firms downgraded or slashed price targets on the stock.

Q3 Revenue: $380.9 million, versus estimates of $391.979 million

Q3 EPS: 65 cents, versus estimates of 77 cents

U.S. revenue was up approximately 43% on a quarter-over-quarter basis due to higher shipments to distributors. Meanwhile, revenues in Europe fell approximately 15% quarter-over-quarter, driven by a "further softening" in European demand.

Enphase shipped 172.9 megawatt hours of IQ batteries in the quarter and shipped approximately 1,176,000 microinverters from its contract manufacturing facilities in the U.S.

The company said it generated $170.1 million in cash flow from operations and $161.3 million in free cash flow during the quarter. Enphase ended the quarter with $1.77 billion in cash, cash equivalents and marketable securities.

Enphase forecasted fourth-quarter revenue of $360 million to $400 million. The company said it expects third quarter gross margin of 47% to 50%, or 49% to 52% on an adjusted basis.

See Also: TSMC Alerts US After Its Chip Is Found In Huawei’s AI Product, Potentially Violating Export Rules

Enphase shares fell about 8% when the report was released. Multiple other solar names including SolarEdge Technologies Inc ( SEDG ) and Sunrun Inc ( RUN ) also fell in sympathy with Enphase. The selling pressure intensified on Wednesday as multiple analysts weighed in.

Janney Montgomery Scott analyst Sean Milligan downgraded Enphase from Buy to Neutral and set a price target of $83.

Guggenheim analyst Joseph Osha downgraded Enphase from Neutral to Sell and set a price target of $73.

Morgan Stanley analyst Andrew Percoco maintained Enphase with an Equal-Weight and lowered the price target from $102 to $93.

Oppenheimer analyst Colin Rusch maintained Enphase with an Outperform and lowered the price target from $134 to $101.

Piper Sandler analyst Kashy Harrison maintained Enphase with a Neutral and lowered the price target from $105 to $85.

ENPH Price Action: Enphase shares were down 17% at $76.56 Wednesday morning, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DTE Energy raises capex plan, fourth-quarter profit falls on lower rates
DTE Energy raises capex plan, fourth-quarter profit falls on lower rates
Feb 13, 2025
Feb 13 (Reuters) - DTE Energy ( DTE ) raised its five-year capital expenditure plan by $5 billion on Thursday, after posting a fall in fourth-quarter profit as the utility took a hit from lower pricing for electricity. With electricity consumption expected to rise to record highs this year and the next, U.S. utilities have been raising their capex plans...
Mullen Automotive to Implement 1-for-60 Reverse Stock Split; Shares Fall
Mullen Automotive to Implement 1-for-60 Reverse Stock Split; Shares Fall
Feb 13, 2025
12:04 PM EST, 02/13/2025 (MT Newswires) -- Mullen Automotive ( MULN ) said Thursday it will implement a 1-for-60 reverse stock split to help bring the company into compliance with Nasdaq's $1 minimum bid price requirement for continued listing. The electric vehicle manufacturer said it expects its shares to start trading on a split-adjusted basis Feb. 18. The company's shares...
Novartis Faces 'Sharp Deceleration' in Growth in Mid-2025, UBS Says
Novartis Faces 'Sharp Deceleration' in Growth in Mid-2025, UBS Says
Feb 13, 2025
12:01 PM EST, 02/13/2025 (MT Newswires) -- Novartis ( NVS ) is facing a sharp deceleration in growth in mid-2025 amid patent expiries and limited newsflow levers, UBS Securities said in a Wednesday note. According to UBS, Novartis' ( NVS ) 2025 guidance illustrates headwinds from mid-year, with earnings before interest and taxes to grow by high teens in H1...
Diebold Nixdorf's Full-Year Outlook 'Impressive,' Wedbush Says
Diebold Nixdorf's Full-Year Outlook 'Impressive,' Wedbush Says
Feb 13, 2025
12:01 PM EST, 02/13/2025 (MT Newswires) -- Diebold Nixdorf's ( DBD ) 2025 outlook was impressive, while its share repurchase plan indicates confidence in delivering continued free cash flow growth, Wedbush Securities said Thursday. On Wednesday, the company said it expected flat to low-single-digit revenue growth in 2025 and free cash flow of $190 million to $210 million. Diebold also...
Copyright 2023-2026 - www.financetom.com All Rights Reserved